Member Info for Bazzaman

Merry Xmas Tom, hope you and the family are all keeping well. Here's to a happy and prosperous 2023.
BOL

Here's the link, replace xxxxxx with vox markets (one word)
https://www.**********.co.uk/articles/jeremy-skillington-of-poolbeg-pharma-first-time-rsv-drug-candidates-have-been-identified-using-ai-bef0a42
GLA

More good news from MicroSalt prior to its anticipated 2023 IPO. Hannaford Supermarkets is a major retail chain in the Northeastern United States, operating 185 stores in Maine, New York, Massachusetts, New Hampshire, and Vermont, most with full-service pharmacies.

Good article on vox markets this morning as well. Replace the xxxxxx with vox markets to read it.
https://www.**********.co.uk/articles/tekcapital-s-microsalt-announces-partnership-with-major-us-retailer-fae4c78
GLA

Yes, he is. I'm expecting an update early in the New Year.
GLA

Simon Thompson is on holiday from 24th November until the New Year so no update expected yet.
GLA

Nice update Elric, exciting times ahead.
GLA

I always try and filter negativity on these chat boards as they don't align with my own views. I'm happy with my own analysis and judgement and believe both HVIVO & POLB will have a good 2023 and the SP should respond accordingly. There are plenty of filtered folk on these chat boards so I can't comment on these guys as I don't see them.
GLA

Better to see the green bins instead, chat boards have a habit of blurring your own judgement IMHO. Keep the faith Moni, expecting good things in 2023 for both POLB & HVIVO.
BOL

Given that Jeremy did one earlier for POLB, expected one on vox from Mo as well.
Only 12 mins this one.
GLA

He's filtered so I don't have a clue what he says & I don't care.
GLA

21 minutes covering:
0:47 Stated milestones hit throughout a year of major newsflow for the company, and strengthening the team to advance business development and clinical studies
2:51 Describing the unique “capital light” business model and its advantages
4:07 The use of artificial intelligence in the drug discovery process, deals signed with AI partners, and upcoming milestones for AI analysis
9:06 Progress of POLB 001, including the completion of its human challenge study without serious adverse events and aims to be partner-ready in 2023
10:54 What’s next on the road to POLB 001 commercialisation
12:02 The renewed focus on infectious diseases, and government support for infectious disease drug development as part of pandemic preparedness plans
13:43 The advantages of orally delivered vaccines, Poolbeg’s collaboration with encapsulation specialist AnaBio on obesity and diabetes treatments, and plans for an exploratory trial in 2023
16:24 Progress on other drugs in the pipeline, POLB 002 and POLB 003
18:09 Balance sheet strength supporting programmes through to commercialisation
19:01 Seeking out further potential drug candidates

It's vox markets and can be seen by going to their website.

Hopefully JPM will close their short now that Sandeep is retiring. Interesting to see how our relationship with Newcrest evolves with new leadership.
GLA

TW gave a pretty good balanced view in last night's bearcast which has just been published. He wasn't happy with placing but better now than in a few months time was his view. Overall still looking forward to seeing how Croda plays out as well and expects SP to recover during 2023.
GLA

Looks like a blue start to the day, let's hope it can keep it up.
GLA

Placing RNS out & completed. Time to look forward to 2023 & leave 2022 behind. Busy & exciting times ahead IMHO.
GLA

Jeremy didn't get to my question but would be good to know whether Q2 2023 updates are expected in April or June.
Interesting presentation and looking forward to further updates in the coming months.
GLA

Investor meet to start at 17.30
GLA

vox markets
https://www.**********.co.uk/articles/jeremy-skillington-of-poolbeg-pharma-licence-acquired-to-use-innovative-oral-delivery-technology-to-address-large-fast-growing-opportunity-0ed0c87